Skip to Content

ZA47 (Divalproex Sodium Extended-Release 250 mg)

Pill with imprint ZA47 is White, Capsule-shape and has been identified as Divalproex Sodium Extended-Release 250 mg. It is supplied by BluePoint Laboratories.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA47

Divalproex Sodium Extended-Release

Imprint
ZA47
Strength
250 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
BluePoint Laboratories

Labelers / Repackagers

NDC CodeLabeler / Repackager
68001-0105
68084-0310 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.